GLP-1s not a ‘lifestyle product’
Health experts in Malaysia are warning against the misuse of GLP-1 receptor agonist medications, which are increasingly sought for weight loss. They emphasize that these drugs require strict medical supervision to avoid serious side effects like acute pancreatitis.
Why it matters
As demand for weight-loss drugs surges, public health officials are concerned about the risks of unregulated use and the potential for health complications.
PETALING JAYA: Injectable medicines, which are used to treat Type 2 diabetes and obesity, must be used responsibly under proper medical supervision, say health experts.
They advise patients using these medications to remain vigilant for warning signs and seek immediate medical attention if symptoms develop.
Universiti Kebangsaan Malaysia’s (UKM) public health specialist Prof Dr Sharifa Ezat Wan Puteh said these medicines are beneficial for suitable patients when prescribed and monitored appropriately.
“These drugs should be prescribed by trained healthcare professionals after carefully weighing the benefits and risks of each treatment and tailoring them to each patient’s condition and concerns.
“Under the right circumstances, the treatment can benefit obese patients by promoting weight loss, reducing the effects of metabolic syndrome and improving diabetes control,” she said.
ASLO READ : Demand for weight-loss drugs on the rise, say pharmacists
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in